Cipla Ltd
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filing Details / Description
Please find enclosed press release titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)"